Header Logo

Connection

Kabirullah Lutfy to Pain Measurement

This is a "connection" page, showing publications Kabirullah Lutfy has written about Pain Measurement.
Connection Strength

0.960
  1. Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors. J Neurosci. 2003 Nov 12; 23(32):10331-7.
    View in: PubMed
    Score: 0.214
  2. Tolerance develops to the antinociceptive and motor impairing effects of ACEA-1416, a NMDA receptor antagonist, in the formalin and rotarod test in mice. Pharmacol Res. 1998 Apr; 37(4):295-302.
    View in: PubMed
    Score: 0.145
  3. ACEA-1011, a novel NMDA receptor/glycine site antagonist, produces antinociception but not tolerance in the formalin test in mice. NIDA Res Monogr. 1995; 147:220-33.
    View in: PubMed
    Score: 0.116
  4. Stress-induced analgesia and endogenous opioid peptides: the importance of stress duration. Eur J Pharmacol. 2011 Jan 15; 650(2-3):563-7.
    View in: PubMed
    Score: 0.087
  5. Orphanin FQ/nociceptin attenuates the development of morphine tolerance in rats. Br J Pharmacol. 2001 Oct; 134(3):529-34.
    View in: PubMed
    Score: 0.046
  6. Blockade of mu-opioid receptors reveals the hyperalgesic effect of orphanin FQ/nociceptin in the rat hot plate test. Br J Pharmacol. 2000 Dec; 131(8):1684-8.
    View in: PubMed
    Score: 0.044
  7. Effects of ACEA-1328, a NMDA receptor/glycine site antagonist, on U50,488H-induced antinociception and tolerance. Eur J Pharmacol. 1999 Nov 12; 384(1):1-5.
    View in: PubMed
    Score: 0.041
  8. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine. Pharmacol Res. 1999 Nov; 40(5):435-42.
    View in: PubMed
    Score: 0.040
  9. Tolerance develops to the inhibitory effect of orphanin FQ on morphine-induced antinociception in the rat. Neuroreport. 1999 Jan 18; 10(1):103-6.
    View in: PubMed
    Score: 0.038
  10. ACEA-1328, an NMDA receptor antagonist, increases the potency of morphine and U50,488H in the tail flick test in mice. Pharmacol Res. 1998 Dec; 38(6):453-60.
    View in: PubMed
    Score: 0.038
  11. Antinociceptive effects of NMDA and non-NMDA receptor antagonists in the tail flick test in mice. Pain. 1997 Mar; 70(1):31-40.
    View in: PubMed
    Score: 0.034
  12. Attenuation of nociceptive responses by ACEA-1021, a competitive NMDA receptor/glycine site antagonist, in the mice. Brain Res. 1996 Dec 16; 743(1-2):17-23.
    View in: PubMed
    Score: 0.033
  13. Differential sensitivity of mice bred for stress-induced analgesia to morphine and ACEA-1011 in the formalin test. Pharmacol Biochem Behav. 1996 Jun; 54(2):495-500.
    View in: PubMed
    Score: 0.032
  14. Blockade of morphine tolerance by ACEA-1328, a novel NMDA receptor/glycine site antagonist. Eur J Pharmacol. 1995 Jan 24; 273(1-2):187-9.
    View in: PubMed
    Score: 0.029
  15. Differential regulation of prohormone convertase 1/3, prohormone convertase 2 and phosphorylated cyclic-AMP-response element binding protein by short-term and long-term morphine treatment: implications for understanding the "switch" to opiate addiction. Neuroscience. 2008 Oct 15; 156(3):788-99.
    View in: PubMed
    Score: 0.019
  16. Species differences in mu- and delta-opioid receptors. Eur J Pharmacol. 1991 Jan 25; 193(1):105-8.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.